Patent · US Active

Implants for the treatment of dopamine associated states

US10278916B2 · kind B2 · utility

0Cited by
9References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 18, 2014
Grant dateMay 7, 2019
Priority date—
Expiry dateDec 18, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Biodegradable implants comprising dopamine modulating compounds are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.